When I was a Director of National Accounts for Sandoz/Geneva 15 years ago, they spoke of a new class of drug called Biosimilars . They are just beginning to come to market.
Here is one that was just approved from my old company, read more here:
-
(860) 422-4747
Info@pprxsolutions.com
